Cohen Investment Groups adds PGNX to its conviction buy list PT $17
We have added 120,000 shares of PGNX at $5.45 - $5.60 average.
PSMA ADC is the best in class for prostate cancer compared to
Xofigo = overall survial rate 11 months vs 14 months ( 3 more months ) Annual Sales = $$$
Xtandi = serious side effects, overall survial rate 30.2 months vs 32.4 moths ( 2 more months ) Annual Sales = $$$
Zytiga = serious side effects, overall survival rate not significant as per agencies. 30.1 months vs 35.3 months ( 5 more months ) Annual Sales = $$$
Provenge = It is important to note that in the PROVENGE clinical trial, the main goal was not to lower PSA levels—it was to extend life. So even if your PSA levels do not go down, PROVENGE may help you live longer.
I have been following this group
daily I ckick on his username to see latest calls
last call I made money on gale
I bought gale at $4 and sold st $5.50 that too in 8 trading days
I will buy pgnx tomorrow.